The University of Arkansas for Medical Sciences (UAMS) is the State’s only comprehensive academic health center, with five colleges, a graduate school, a new 540,000-square-foot hospital, six centers of excellence and a statewide network of regional centers. UAMS has 2,652 students and 733 medical residents. Its centers of excellence include the Winthrop P. Rockefeller Cancer Institute, the Jackson T. Stephens Spine & Neurosciences Institute, the Myeloma Institute for Research and Therapy, the Harvey & Bernice Jones Eye Institute, the Psychiatric Research Institute and the Donald W. Reynolds Institute on Aging. It is the state’s largest public employer with more than 10,000 employees, including nearly 1,150 physicians who provide medical care to patients at UAMS, Arkansas Children’s Hospital, the VA Medical Center and UAMS’ Area Health Education Centers throughout the state. Visit www.uams.edu or www.uamshealth.com.
The largest-ever research grant earned by the UAMS has reached 17 faculty members dedicated to clinical and translational research.
The UAMS Center for Clinical and Translational Research (CCTR) recently awarded more than $1.1 million to faculty dedicated to pursuing clinical and translational research in two separate programs. The CCTR Pilot Study program awarded more than $973,000 to 15 investigators across nine UAMS departments, while the KL2 Mentored Clinical Research Scholar program will provide nearly $200,000 of support for two winners.
The UAMS CCTR is one of 46 medical research institutions working together as a national consortium to improve the way biomedical research is conducted across the country. The consortium, funded through Clinical and Translational Science Awards (CTSA), shares a common vision to reduce the time it takes for laboratory discoveries to become treatments for patients, and to engage communities in clinical research efforts. It also is fulfilling the critical need to train a new generation of clinical researchers. The CTSA program is led by the National Center for Research Resources (NCRR), part of National Institutes of Health (NIH).
UAMS BioVentures serves as the Technology Licensing Office, spin-out business accelerator, and the portal to all of the University's intellectual property and economic development programs. For more information, please visit www.uams.edu/bioventures or contact Michael G. Douglas, PhD firstname.lastname@example.org or Charlie Cook at (501) 686-6696 – e-mail CACook@uams.edu
The University of Arkansas for Medical Sciences, through its Technology Licensing Office, UAMS BioVentures, is seeking global, commercial partners to out-license its' innovations for the purpose of taking its discoveries to the world's medical and healthcare market places.
Mr. Christopher Fasel
Associate Director or Licensing
UAMS BioVentures - TLO
Dr. Michael Douglas
Clients in focus...